Literature DB >> 12705478

Expression of the Na(+)/I(-) symporter in invasive ductal breast cancer.

Lucyna Rudnicka1, Anna Sińczak, Piotr Szybiński, Bogdan Huszno, Jerzy Stachura.   

Abstract

The function of the sodium iodide symporter (Na(+)/I(-), (NIS), a membrane protein that mediates iodide transport into cells, is the best described in the thyroid cells. NIS is also found in mammary cells during lactation and in breast carcinoma cells. The aim of this study was evaluation of incidence and grade of NIS expression in invasive ductal breast cancer. Immunohistochemistry using a panel of antibodies against NIS was carried out in surgical paraffin-embedded tissue obtained from 50 patients with invasive ductal breast carcinoma. NIS expression was found in 45 (90%) cases. The demonstration of NIS expression in breast carcinoma cells may provide a novel approach to its diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705478

Source DB:  PubMed          Journal:  Folia Histochem Cytobiol        ISSN: 0239-8508            Impact factor:   1.698


  4 in total

1.  Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

Authors:  S J Beyer; R E Jimenez; C L Shapiro; J Y Cho; S M Jhiang
Journal:  Breast Cancer Res Treat       Date:  2008-05-26       Impact factor: 4.872

2.  The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue.

Authors:  James Ryan; Catherine E Curran; Emer Hennessy; John Newell; John C Morris; Michael J Kerin; Roisin M Dwyer
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

3.  Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer.

Authors:  Sasha J Beyer; Xiaoli Zhang; Rafael E Jimenez; Mei-Ling T Lee; Andrea L Richardson; Kun Huang; Sissy M Jhiang
Journal:  BMC Res Notes       Date:  2011-10-11

Review 4.  Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer.

Authors:  Salvatore Micali; Stefania Bulotta; Cinzia Puppin; Angelo Territo; Michele Navarra; Giampaolo Bianchi; Giuseppe Damante; Sebastiano Filetti; Diego Russo
Journal:  BMC Cancer       Date:  2014-04-30       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.